Patient-reported outcome measures in patients with familial cerebral cavernous malformations: results from the Treat_CCM trial

Patient-reported outcome measures in patients with familial cerebral cavernous malformations: results from the Treat_CCM trial

BackgroundThe Phase 1/2 Treat_CCM randomized controlled trial for people with familial cerebral cavernous malformations (FCCMs) confirmed the safety of propranolol and suggested beneficial effects on intracerebral hemorrhage or new focal neurological deficits, but the effects on patient-reported out...

Full description

Bibliographic Details
Main Authors: Jennifer M. T. A. Meessen, Giorgia Abete-Fornara, Barbara Zarino, Marco Castori, Laura Tassi, Maria R. Carriero, Q. G. D'Alessandris, R. Al-Shahi Salman, Adriana Blanda, Enrico B. Nicolis, Deborah Novelli, Maria Caruana, Antonella Vasamì, Silvia Lanfranconi, Roberto Latini
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-02-01
Series:Frontiers in Neurology
Subjects:
familial cerebral cavernous malformation
neurology
patient-reported outcome measures (PROMs)
depression
anxiety
quality of life
Online Access:https://www.frontiersin.org/articles/10.3389/fneur.2024.1338941/full

Internet

https://www.frontiersin.org/articles/10.3389/fneur.2024.1338941/full

Similar Items